Long QTc interval and torsade de pointes caused by fluconazole (Q34569221)

3 August 2017

title

Long QTc interval and torsade de pointes caused by fluconazole (English)

1 reference

3 August 2017

1 reference

C Phu Pham

1 reference

3 August 2017

Peter W de Feiter

series ordinal

1 reference

3 August 2017

P Hugo M van der Kuy

series ordinal

1 reference

3 August 2017

Walther Nka van Mook

series ordinal

1 reference

3 August 2017

language of work or name

English

0 references

publication date

18 July 2006

1 reference

Annals of Pharmacotherapy

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

issue

7-8

1 reference

3 August 2017

page(s)

1456-1461

1 reference

Long QT syndromes and torsade de pointes

3 August 2017

cites work

1 reference

A practical approach to torsade de pointes

21 January 2018

1 reference

QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience

21 January 2018

1 reference

Drug-induced prolongation of the QT interval

21 January 2018

1 reference

Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline

21 January 2018

1 reference

Probable case of torsades de pointes induced by fluconazole

21 January 2018

1 reference

Long QT syndrome and torsade de pointes in a patient receiving fluconazole

21 January 2018

1 reference

Fluconazole-induced torsade de pointes

21 January 2018

1 reference

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

21 January 2018

1 reference

The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome

21 January 2018

1 reference

What Clinicians Should Know About the QT Interval

21 January 2018

1 reference

Risk stratification in the long-QT syndrome.

21 January 2018

1 reference

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg.

21 January 2018

1 reference

Physician-induced torsade de pointes--therapeutic implications.

21 January 2018

1 reference

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

21 January 2018

1 reference

Electrocardiographic changes in stroke patients without primary heart disease

21 January 2018

1 reference

Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1G741

1 reference

3 August 2017

1 reference